BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1720921)

  • 1. Immunohistochemical progesterone receptor assay. Measurement by image analysis.
    el-Badawy N; Cohen C; Derose PB; Check IJ; Sgoutas D
    Am J Clin Pathol; 1991 Dec; 96(6):704-10. PubMed ID: 1720921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical estrogen receptor assay: quantitation by image analysis.
    el-Badawy N; Cohen C; DeRose PB; Sgoutas D
    Mod Pathol; 1991 May; 4(3):305-9. PubMed ID: 2068055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma.
    Baddoura FK; Cohen C; Unger ER; DeRose PB; Chenggis M
    Mod Pathol; 1991 Jan; 4(1):91-5. PubMed ID: 1708502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
    Layfield LJ; Saria EA; Conlon DH; Kerns BJ
    J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.
    Gasparini G; Pozza F; Dittadi R; Meli S; Cazzavillan S; Bevilacqua P
    J Cancer Res Clin Oncol; 1992; 118(7):557-63. PubMed ID: 1378057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical detection of progesterone receptor by monoclonal KD-68 antibody in operable breast cancer: correlations with biochemical assay, pathological features and cell proliferative rate.
    Bevilacqua P; Pea M; Gasparini G
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1595-602. PubMed ID: 2687004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative analysis of various biochemical and immunohistochemical methods for evaluating hormone receptors in breast carcinoma].
    Gallo C; Orlassino R; Demarchi A; Vallero P; Vineis C
    Pathologica; 2002 Aug; 94(4):176-80. PubMed ID: 12325415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay.
    Wilbur DC; Willis J; Mooney RA; Fallon MA; Moynes R; di Sant'Agnese PA
    Mod Pathol; 1992 Jan; 5(1):79-84. PubMed ID: 1371874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
    Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
    Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis.
    Esteban JM; Kandalaft PL; Mehta P; Odom-Maryon TL; Bacus S; Battifora H
    Am J Clin Pathol; 1993 Jan; 99(1):32-8. PubMed ID: 8422013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical analysis of progesterone receptors in breast cancer.
    Masood S; Dee S; Goldstein JD
    Am J Clin Pathol; 1991 Jul; 96(1):59-63. PubMed ID: 1712544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor immunohistochemical quantitation compared with cytosolic assay: correlation with prognosis in breast cancer.
    Lohmann C; Gibney E; Cotsonis G; Lawson D; Cohen C
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):49-53. PubMed ID: 11277415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
    Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
    Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
    Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
    J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
    Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
    Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay.
    Gritzapis AD; Baxevanis CN; Missitzis I; Katsanou ES; Alexis MN; Yotis J; Papamichail M
    Breast Cancer Res Treat; 2003 Jul; 80(1):1-13. PubMed ID: 12889594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.